| HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy A Marcu, L Bichmann, L Kuchenbecker, DJ Kowalewski, ... Journal for immunotherapy of cancer 9 (4), e002071, 2021 | 230* | 2021 |
| Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry LK Freudenmann, A Marcu, S Stevanović Immunology 154 (3), 331-345, 2018 | 124 | 2018 |
| Autophagic digestion of Leishmania major by host macrophages is associated with differential expression of BNIP3, CTSE, and the miRNAs miR-101c, miR-129 … B Frank, A Marcu, AL de Oliveira Almeida Petersen, H Weber, C Stigloher, ... Parasites & vectors 8, 1-31, 2015 | 100 | 2015 |
| The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy T Bilich, A Nelde, L Bichmann, M Roerden, HR Salih, DJ Kowalewski, ... Blood, The Journal of the American Society of Hematology 133 (6), 550-565, 2019 | 77 | 2019 |
| BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity ZA Bittner, X Liu, M Mateo Tortola, A Tapia-Abellán, S Shankar, ... Journal of Experimental Medicine 218 (11), 2021 | 62 | 2021 |
| TAPBPR mediates peptide dissociation from MHC class I using a leucine lever FT Ilca, A Neerincx, C Hermann, A Marcu, S Stevanović, JE Deane, ... Elife 7, e40126, 2018 | 50 | 2018 |
| The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy MC Neidert, DJ Kowalewski, M Silginer, K Kapolou, L Backert, ... Acta neuropathologica 135, 923-938, 2018 | 48 | 2018 |
| Immunopeptidomics-guided warehouse design for peptide-based immunotherapy in chronic lymphocytic leukemia A Nelde, Y Maringer, T Bilich, HR Salih, M Roerden, JS Heitmann, ... Frontiers in immunology 12, 705974, 2021 | 38 | 2021 |
| Guidance document: validation of a high-performance liquid chromatography-tandem mass spectrometry immunopeptidomics assay for the identification of HLA class I ligands … M Ghosh, M Gauger, A Marcu, A Nelde, M Denk, H Schuster, ... Molecular & Cellular Proteomics 19 (3), 432-443, 2020 | 35 | 2020 |
| Inhibitory effect of phenothiazine-and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase A Marcu, U Schurigt, K Müller, H Moll, RL Krauth-Siegel, H Prinz European Journal of Medicinal Chemistry 108, 436-443, 2016 | 32 | 2016 |
| Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade F Berner, D Bomze, C Lichtensteiger, V Walter, R Niederer, O Hasan Ali, ... Science Immunology 7 (75), eabn9644, 2022 | 28 | 2022 |
| Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models M Lübke, S Spalt, DJ Kowalewski, C Zimmermann, L Bauersfeld, A Nelde, ... Journal of Experimental Medicine 217 (3), e20191164, 2019 | 28 | 2019 |
| Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues P Kubiniok, A Marcu, L Bichmann, L Kuchenbecker, H Schuster, ... Iscience 25 (2), 2022 | 24 | 2022 |
| Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors A Marcu, A Schlosser, A Keupp, N Trautwein, P Johann, M Wölfl, J Lager, ... Journal for immunotherapy of cancer 9 (10), e003404, 2021 | 19 | 2021 |
| Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to … P Gierlich, V Lex, A Technau, A Keupp, L Morper, A Glunz, H Sennholz, ... Cancer Immunology, Immunotherapy 69 (6), 1029-1042, 2020 | 18 | 2020 |
| Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma T Bilich, A Nelde, J Bauer, S Walz, M Roerden, HR Salih, K Weisel, ... Blood cancer journal 10 (2), 24, 2020 | 18 | 2020 |
| Systematic discovery of neoepitope–HLA pairs for neoantigens shared among patients and tumor types HR Gurung, AJ Heidersbach, M Darwish, PPF Chan, J Li, M Beresini, ... Nature Biotechnology 42 (7), 1107-1117, 2024 | 17 | 2024 |
| Citrullinated epitopes identified on tumour MHC class II by peptide elution stimulate both regulatory and Th1 responses and require careful selection for optimal anti-tumour … P Symonds, A Marcu, KW Cook, RL Metheringham, LG Durrant, ... Frontiers in Immunology 12, 764462, 2021 | 15 | 2021 |
| Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival F Berner, R Niederer, JJ Luimstra, OT Pop, AK Jochum, MT Purde, ... Oncoimmunology 10 (1), 2006893, 2021 | 6 | 2021 |
| Therapeutic vaccine strategies to induce tumor-specific T-cell responses A Marcu, M Eyrich Bone Marrow Transplantation 54 (Suppl 2), 806-809, 2019 | 2 | 2019 |
